| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +7.64M | 100% | $0.07 | +$500K |
| Sells | 0 | ||||
| Net | +1 | +7.64M | 100% | +$500K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yair Schneid | 10%+ Owner | $2.1M | Apr 17, 2024 | ||
| Rochel Soffer | 10%+ Owner | $1.15M | Apr 16, 2024 | ||
| Nancy T. Chang | Director, 10%+ Owner | $500K | +$500K | Feb 24, 2025 | |
| Robert A. Beardsley | Chief Operating Officer | $243K | Feb 25, 2023 | ||
| Altamont Pharmaceutical Holdings, LLC | 10%+ Owner | $158K | Dec 31, 2023 | ||
| Mark Bachleda | Chief Commercial Officer | $24.7K | Mar 16, 2023 | ||
| Chris Degnan | Chief Financial Officer | $22.5K | Mar 13, 2023 | ||
| Mel Sorensen | President and CEO, Director | $9.75K | Nov 20, 2025 | ||
| Eugene P. Kennedy | Chief Medical Officer | Feb 25, 2023 | |||
| Linda West | Director | Jul 1, 2023 | |||
| Holmlund Jon T | Chief Medical Officer | Feb 28, 2022 | |||
| Michael Powell | Director | Jun 14, 2023 | |||
| Kevin G. Lokay | Director | Feb 24, 2025 | |||
| Lawrence M. Alleva | Director | Feb 24, 2025 | |||
| Jennifer Evans Stacey | Chief Legal & Compliance Officer | Feb 25, 2023 | |||
| Emmett Cunningham | Director | Jun 14, 2023 | |||
| Joel F. Sussman | Chief Accounting Officer | May 1, 2025 | |||
| R. Michael Friedman | Director | Feb 24, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|